Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic scleroderma.

D L Tuffanelli1

  • 1Department of Dermatology, University of California-San Francisco.

The Medical Clinics of North America
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

This article focuses on systemic scleroderma, a complex autoimmune disease. It highlights the diverse manifestations and challenges in diagnosing and managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Localized scleroderma.

Seminars in cutaneous medicine and surgery·1998
Same author

Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology.

Journal of the American Academy of Dermatology·1996
Same author

Guidelines of care for dermatomyositis. American Academy of Dermatology.

Journal of the American Academy of Dermatology·1996
Same author

Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology.

Journal of the American Academy of Dermatology·1996
Same author

Collagen-vascular disease: An update.

Journal of the American Academy of Dermatology·1993
Same author

False-positive Lyme antibody test in morphea.

Journal of the American Academy of Dermatology·1993

Area of Science:

  • Rheumatology and Immunology
  • Autoimmune Diseases
  • Dermatology

Background:

  • Scleroderma is a group of rare diseases characterized by hardening and tightening of the skin and connective tissues.
  • It encompasses localized scleroderma, overlap syndromes, sclerodermoid conditions, and systemic scleroderma.
  • Systemic scleroderma (SSc) is a severe autoimmune condition affecting multiple organ systems.

Purpose of the Study:

  • To provide a comprehensive overview of systemic scleroderma.
  • To emphasize the key features and clinical significance of SSc.
  • To serve as a resource for understanding SSc within the broader spectrum of scleroderma.

Main Methods:

  • Review of existing literature on scleroderma and systemic scleroderma.
  • Synthesis of information regarding classification, pathogenesis, and clinical presentation of SSc.

Related Experiment Videos

  • Focus on systemic manifestations and diagnostic considerations.

    • Main Results:

    • Systemic scleroderma is a distinct and serious subset of scleroderma.
    • Understanding the heterogeneity of scleroderma is crucial for accurate diagnosis.
    • SSc presents with a wide range of symptoms affecting internal organs.

    Conclusions:

    • Systemic scleroderma requires specialized medical attention due to its complexity.
    • Early recognition and management are vital for improving patient outcomes.
    • Further research is needed to fully elucidate SSc pathogenesis and treatment.